Select Publications
Journal articles
2018, 'Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-20015-x
,2018, 'Treatment for pharyngeal gonorrhoea under threat', The Lancet Infectious Diseases, 18, pp. 1175 - 1177, http://dx.doi.org/10.1016/S1473-3099(18)30610-8
,2018, 'Direct detection of penA gene associated with ceftriaxone-resistant neisseria gonorrhoeae FC428 strain by using PCR', Emerging Infectious Diseases, 24, pp. 1573 - 1575, http://dx.doi.org/10.3201/eid2408.180295
,2018, 'Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin', The Lancet Infectious Diseases, 18, pp. 717 - 718, http://dx.doi.org/10.1016/S1473-3099(18)30340-2
,2018, 'Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017', Journal of Antimicrobial Chemotherapy, 73, pp. 1242 - 1246, http://dx.doi.org/10.1093/jac/dky017
,2018, 'Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain', Emerging Infectious Diseases, 24, pp. 735 - 740, http://dx.doi.org/10.3201/eid2404.171873
,2018, 'Australian Gonococcal Surveillance Programme Annual Report, 2016', Communicable diseases intelligence (2018), 42
,2018, 'Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report', Clinical and Experimental Ophthalmology, 47, pp. 20 - 25, http://dx.doi.org/10.1111/ceo.13364
,2018, 'Whole genome sequencing to characterise azithromycin resistant Neisseria gonorrhoeae from New South Wales in 2017', Pathology, 50, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2017.12.117
,2017, 'Australian Meningococcal Surveillance Programme annual report, 2016', Communicable diseases intelligence quarterly report, 41, pp. E369 - E382
,2017, 'Epidemiology of invasive meningococcal b disease in Australia, 1999-2015: Priority populations for vaccination', Medical Journal of Australia, 207, pp. 382 - 387, http://dx.doi.org/10.5694/mja16.01340
,2017, 'The Australian Gonococcal Surveillance Programme 1979-2017', MICROBIOLOGY AUSTRALIA, 38, pp. 175 - 179, http://dx.doi.org/10.1071/MA17062
,2017, 'Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017', Communicable diseases intelligence quarterly report, 41, pp. E241 - E242
,2017, 'MENINGOCOCCAL SURVEILLANCE AUSTRALIA REPORTING PERIOD 1 APRIL TO 30 JUNE 2017', COMMUNICABLE DISEASES INTELLIGENCE, 41, pp. E241 - E242, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423988300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia', Emerging Infectious Diseases, 23, pp. 1478 - 1485, http://dx.doi.org/10.3201/eid2309.170427
,2017, 'Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action', PLoS Medicine, 14, pp. e1002344, http://dx.doi.org/10.1371/journal.pmed.1002344
,2017, 'Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines', PLoS Medicine, 14, http://dx.doi.org/10.1371/journal.pmed.1002366
,2017, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2017', Communicable diseases intelligence quarterly report, 41, pp. E201
,2017, 'Australian Gonococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, 41
,2017, 'Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes', Journal of Antimicrobial Chemotherapy, 72, pp. 705 - 711, http://dx.doi.org/10.1093/jac/dkw452
,2017, 'Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: Implications for antimicrobial resistance surveillance?', Journal of Antimicrobial Chemotherapy, 72, pp. 407 - 409, http://dx.doi.org/10.1093/jac/dkw406
,2017, 'Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia', The Lancet Infectious Diseases, 17, pp. 133 - 134, http://dx.doi.org/10.1016/S1473-3099(17)30007-5
,2017, 'Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience from Two Australian Tertiary Pediatric Facilities', Pediatric Infectious Disease Journal, 36, pp. 20 - 24, http://dx.doi.org/10.1097/INF.0000000000001345
,2017, 'Antimicrobial resistance in Neisseria gonorrhoeae in Australia', Pathology, 49, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2016.12.123
,2017, 'Mixed gonococcal infections and antimicrobial resistance surveillance', Pathology, 49, pp. S115 - S115, http://dx.doi.org/10.1016/j.pathol.2016.12.337
,2016, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016', Communicable diseases intelligence quarterly report, 40, pp. E557 - E559
,2016, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, 40, pp. E554 - E556
,2016, 'Australian Meningococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, 40, pp. E503 - E511
,2016, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2016', Communicable diseases intelligence quarterly report, 40, pp. E560
,2016, 'Rise in invasive serogroup W meningococcal disease in Australia 2013-2015', Communicable diseases intelligence quarterly report, 40, pp. E454 - E459
,2016, 'The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012', Clinical Infectious Diseases, 63, pp. 1591 - 1598, http://dx.doi.org/10.1093/cid/ciw648
,2016, 'From zero to zero in 100 years: Gonococcal antimicrobial resistance', Microbiology Today, 43, pp. 173 - 175, http://dx.doi.org/10.1071/MA16058
,2016, 'Real-time PCR detection of Neisseria gonorrhoeae susceptibility to penicillin', Journal of Antimicrobial Chemotherapy, 71, pp. 3090 - 3095, http://dx.doi.org/10.1093/jac/dkw291
,2016, 'The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization', Journal of Antimicrobial Chemotherapy, 71, pp. 3096 - 3108, http://dx.doi.org/10.1093/jac/dkw288
,2016, 'Identifying factors that lead to the persistence of imported gonorrhoeae strains: A modelling study', Sexually Transmitted Infections, 93, pp. 221 - 225, http://dx.doi.org/10.1136/sextrans-2016-052738
,2016, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, 40, pp. E446
,2016, 'A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae', Diagnostic Microbiology and Infectious Disease, 86, pp. 40 - 43, http://dx.doi.org/10.1016/j.diagmicrobio.2016.04.016
,2016, 'AUSTRALIAN MENINGOCOCCAL SURVEILLANCE PROGRAMMMME, 1 APRIL TO 30 JUNE 2016', COMMUNICABLE DISEASES INTELLIGENCE, 40, pp. E447 - E447, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388538500018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme', Epidemiology and Infection, 144, pp. 2382 - 2391, http://dx.doi.org/10.1017/S0950268816000704
,2016, 'Australian Meningococcal Surveillance Programme annual report, 2014', Communicable diseases intelligence quarterly report, 40, pp. E221 - E228
,2016, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015', Communicable diseases intelligence quarterly report, 40, pp. E179 - E181
,2016, 'A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility', Journal of Antimicrobial Chemotherapy, 71, pp. 353 - 356, http://dx.doi.org/10.1093/jac/dkv366
,2016, 'Complete genome sequences of 11 Haemophilus ducreyi isolates from children with cutaneous lesions in Vanuatu and Ghana', Genome Announcements, 4, http://dx.doi.org/10.1128/genomeA.00459-16
,2016, 'Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin', The Lancet Infectious Diseases, 16, pp. 1005 - 1006, http://dx.doi.org/10.1016/S1473-3099(16)30271-7
,2015, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015', Communicable diseases intelligence quarterly report, 39, pp. E628 - E630
,2015, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2015', Communicable diseases intelligence quarterly report, 39, pp. E631
,2015, 'Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance', The Journal of antimicrobial chemotherapy, 70, pp. 3244 - 3249, http://dx.doi.org/10.1093/jac/dkv274
,2015, 'Detection of neisseria gonorrhoeae isolates from tonsils and posterior oropharynx', Journal of Clinical Microbiology, 53, pp. 3624 - 3626, http://dx.doi.org/10.1128/JCM.01647-15
,2015, 'A New Multidrug-Resistant Strain of Neisseria gonorrhoeae in Australia (vol 371, pg 1850, 2014)', NEW ENGLAND JOURNAL OF MEDICINE, 373, pp. 982 - 982, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360439500027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Australian Gonococcal Surveillance Programme annual report, 2014', Communicable diseases intelligence quarterly report, 39, pp. E347 - E354
,